BFM
PCVX icon

Boothbay Fund Management’s Vaxcyte PCVX Stock Holding History

Boothbay Fund Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.1M Buy
534,163
+12,144
+2% +$660K 0.41% 26
2026
Q1 		$30.3M Buy
522,019
+24,279
+5% +$1.32M 0.39% 19
2025
Q4 		$23M Buy
497,740
+369,009
+287% +$16.5M 0.34% 32
2025
Q3 		$4.64M Buy
128,731
+25,464
+25% +$844K 0.07% 330
2025
Q2 		$3.36M Buy
103,267
+38,109
+58% +$1.25M 0.07% 386
2025
Q1 		$2.46M Buy
+65,158
New +$5.21M 0.06% 380
2023
Q4 		– Sell
-27,919
Closed -$1.42M – 1892
2023
Q3 		$1.42M Buy
27,919
+2,575
+10% +$127K 0.03% 616
2023
Q2 		$1.27M Sell
25,344
-15,333
-38% -$727K 0.03% 735
2023
Q1 		$1.52M Sell
40,677
-5,258
-11% -$223K 0.03% 802
2022
Q4 		$2.2M Buy
+45,935
New +$1.8M 0.05% 565
2022
Q3 		– Sell
-22,733
Closed -$495K – 2516
2022
Q2 		$495K Sell
22,733
-7,636
-25% -$177K 0.01% 1182
2022
Q1 		$733K Buy
30,369
+689
+2% +$15.1K 0.02% 1092
2021
Q4 		$706K Hold
29,680
– – 0.02% 888
2021
Q3 		$753K Sell
29,680
-19,441
-40% -$471K 0.02% 892
2021
Q2 		$1.11M Sell
49,121
-5,810
-11% -$119K 0.04% 643
2021
Q1 		$1.08M Buy
54,931
+25,719
+88% +$647K 0.04% 557
2020
Q4 		$776K Buy
+29,212
New +$1.09M 0.03% 588
2020
Q3 		– Sell
-17,637
Closed -$558K – 1166
2020
Q2 		$558K Buy
+17,637
New +$567K 0.04% 547

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Boothbay Fund Management's PCVX Position: Q2 2026 in Review

Boothbay Fund Management increased its Vaxcyte (PCVX) stake by 2.3% in Q2 2026, buying an estimated $660K and bringing the position to 534,163 shares worth $31.1M. The position accounts for 0.41% of the portfolio, ranked #26.

Boothbay Fund Management first reported a position in PCVX in Q2 2020 and has held it in 18 quarters since. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Boothbay Fund Management held 534,163 shares of Vaxcyte worth $31.1M as of Q2 2026.
  • Boothbay Fund Management bought 12,144 Vaxcyte shares in Q2 2026, an estimated $660K.
  • Vaxcyte made up 0.41% of Boothbay Fund Management's portfolio in Q2 2026, its #26 holding.
  • Boothbay Fund Management first reported a position in Vaxcyte in Q2 2020 and has held it in 18 quarters since.
  • 332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.